Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.

The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

KATE MOSS once said “nothing tastes as good as skinny feels” and promptly became a jet-setting multimillionaire living off a ...

Ozempic is a brand-name medication containing the active ... Doctors may also prescribe Ozempic off-label to assist with weight loss. Off-label use means a doctor prescribes a medication for ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...